World Young Rheumatic Diseases Day
Word Day, March 18 #wordday2020 World Young Rheumatic Diseases Day is on 18 March aiming to raise the awareness and knowledge level of parents, doctors, primary practitioners, teachers, and the general public to help in early diagnoses, and a quick referral. It aims to improve the level of treatment children receive and their prognosis worldwide….
Escape-pain 2020 conference
The last few places are remaining for the Escape-Pain 2020 conference on 24 March in London. Speakers include the new MSK Director from NHSE, Andrew Bennett, Professor Mike Hurley and Sue Brown, ARMA CEO. See the flyer for more information.
SOMM reviews stand-alone modules
The Society is currently revisiting its strategy and short and long term plans for its course provision. The ‘Theory and Practice of Injection Therapy’ and ‘Advancing Clinical Practice in Musculoskeletal Medicine’ modules, stand-alone or optional modules within the Society’s MSc Musculoskeletal Medicine, are being reviewed within the context of the four pillars of advanced practice,…
Footwear fit for function – how do we choose the right shoes?
The rapid changes in shoe design and the increasing number of choices that occur in the footwear market might make a consumer with painful feet quiver at the thought of buying any new shoes. Yet, humans have been wearing shoes on their feet for thousands of years as protection against the environment. Problems have only…
New how-to guide: non face-to-face clinics
The NHS Long Term Plan includes commitments to remove the need for up to a third of outpatient appointments over the next five years, saving patients 30 million trips to hospital and the NHS more than ã1 billion a year in new expenditure, and to continue to provide patients with a wide choice of options…
Paediatric rheumatology webinar
Upcoming webinar: Paediatric rheumatology: lived experience and psychological needs Friday 27 March 12.30 – 1.30 Around 12,000 children and young people in the UK have a musculoskeletal condition. Supporting them to live the lives they want is an important part of treating their conditions. This webinar will discuss these issues using the example of Juvenile…
NICE Quality Standard – Rheumatoid arthritis in over 16s
In January 2020, NICE published an update on the Quality Standard for rheumatoid arthritis in over 16s (QS33). This quality standard covers assessing, diagnosing and managing rheumatoid arthritis in over 16s. It describes high-quality care in priority areas for improvement. NICE thanked organisations that submitted comments during the consultation period. All consultation comments were considered…
iO research and reports
The Institute of Osteopathy has recently published additional reports, including the impact of Multidisciplinary management of low back pain and sciatica in primary care. This impact report provides an overview of the Plymouth Community Back Pain Service which has delivered a sustainable primary care service with measurable outcomes run by a multidisciplinary team including GPs,…
Raynaud’s Awareness Month February 2020
As detailed in their latest e-news bulletin, this February HMSA will be involved in Marfan Awareness, Raynaud’s Awareness, and at the end of the month, #HMSAaware incorporating Rare Disease Day. Sign up to the HMSA e-news bulletin for more via the www.hypermobility.org website; there’s a subscription form at the bottom of every webpage.
NHS extends testing of non-urgent care waiting times target changes
If you are referred for specialist non-urgent treatment, you currently should expect to be treated within a maximum waiting time of 18 weeks. Over the last year, the NHS has been reviewing this 18-week target. ARMA has been involved in the advisory group looking at this change. The NHS England board meeting on 30 January…